Sign in
4

Changes in Ownership

Pacira BioSciences, Inc. Filed Acc 0001209191-23-023336

Director sold 7,000 shares at $40.72 ($285,040)

  • Director acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brege Laura Director 2023-04-03 Option exercise 10b5-1 +7,000 $29.90 $209,300 17,147 D
Brege Laura Director 2023-04-03 Sale 10b5-1 −7,000 $40.72 $285,040 10,147 D
Derivatives
Brege Laura Director 2023-04-03 Option exercise · Stock Option (Right to Buy) 10b5-1 −7,000 0 D
Open-market sales · 7,000 sh · avg $40.72 · $285,040
Loading xslF345X04/doc4.xml…